Join the Breast Cancer - Adjuvant group to help and get support from people like you.
Breast Cancer - Adjuvant News (Page 5)
What Cancer Screenings Do You Need? A Quick Guide
SATURDAY, Feb. 15, 2025 – Cancer screenings can save lives by detecting cancer early, when treatment is most effective. With an estimated 2 million new cancer cases expected in 2025, regular...
AI Contributes to Early Detection of Clinically Relevant Breast Cancer
THURSDAY, Feb. 13, 2025 – Artificial intelligence (AI) contributes to early detection of clinically relevant breast cancer, according to a study published online Feb. 3 in The Lancet Digital Health....
Pre-Op Immunotherapy May Help Treat Aggressive Breast Cancers
FRIDAY, Feb. 7, 2025 – Giving patients with a common form of breast cancer an immunotherapy drug before surgery appears to boost outcomes, a new phase 3 trial finds. The study involved patients with...
Breast Reduction Can Spur Weight Gain in Young Women
THURSDAY, Feb. 6, 2025 – Many women may opt for a breast reduction if they encounter issues such as recurrent neck, back and shoulder pain. However, a new study suggests a link between these ...
Nivolumab Added to Chemo Improves Response in ER+, HER2− Breast Cancer
THURSDAY, Feb. 6, 2025 – For patients with high-risk, early-stage estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative primary breast cancer (BC), adding...
FDA Approval Expands Earlier Use of Enhertu for Metastatic Breast Cancer
MONDAY, Feb. 3, 2025 – The U.S. Food and Drug Administration has approved Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with unresectable or metastatic hormone receptor ...
FDA Approves Datroway for HR-Positive, HER2-Negative Breast Cancer
FRIDAY, Jan. 31, 2025 -- The U.S. Food and Drug Administration has approved Datroway (datopotamab deruxtecan-dlnk) for adult patients with unresectable or metastatic, hormone receptor (HR)-positive, ...
Adjuvant Trastuzumab Emtansine Improves Overall Survival in HER2+ Breast Cancer
THURSDAY, Jan. 16, 2025 – For patients with human epidermal growth factor receptor 2 (HER2)-positive early breast cancer, adjuvant trastuzumab emtansine (T-DM1) improves overall survival more than...
AI-Supported Double Mammogram Reading Improves Detection Rate
TUESDAY, Jan. 14, 2025 – Artificial intelligence (AI)-supported double-reading mammography is associated with a higher breast cancer detection rate, without affecting the recall rate, compared with...
Weight Gain After Breast Cancer Development Tied to Heart Failure Risk
FRIDAY, Jan. 10, 2025 – For women with newly diagnosed invasive breast cancer (BC), weight gain is associated with an increased risk for heart failure, according to a research letter published...
Nonadherence to Cancer Screening Varies by Screening Type
THURSDAY, Jan. 9, 2025 – Nonadherence to cancer screening varies by screening type and sex, according to a study published online Jan. 3 in JAMA Network Open. Ami E. Sedani, Ph.D., M.P.H., from the...
Physical Activity May Improve Outcomes in People Diagnosed With Cancer
WEDNESDAY, Jan. 8, 2025 – Engaging in any physical activity is associated with a reduced risk for cancer progression and all-cause mortality, according to a study published online Jan. 7 in...
Individuals With Advanced Breast Cancer at Diagnosis More Likely to Have CVD
MONDAY, Jan. 6, 2025 – Individuals with advanced breast cancer at diagnosis are more likely to have prevalent cardiovascular disease (CVD), according to a study published online Jan. 2 in JAMA...
Decrease Seen in In Situ Breast Cancer Since 2009
MONDAY, Jan. 6, 2025 – The incidence of in situ breast cancer has decreased since 2009, consistent with decreasing use of mammography in association with the 2009 U.S. Preventive Services Task Force...
The Heart Disease, Breast Cancer Link
MONDAY, Jan. 6, 2025 – Heart disease and cancer might seem completely unrelated, but these two top causes of death sometimes act in concert. Women with heart disease appear to have a greater risk of...